LP
BLCM

LMR Partners’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

LMR Partners’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-6,384
Closed -$67K – 593
2019
Q3 		$67K Hold
6,384
– – ﹤0.01% 368
2019
Q2 		$109K Buy
+6,384
New +$173K ﹤0.01% 365
2017
Q2 		– Sell
-27,059
Closed -$3.34M – 710
2017
Q1 		$3.34M Buy
+27,059
New +$3.54M 0.32% 62

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LMR Partners's BLCM Position: Q4 2019 in Review

LMR Partners sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q4 2019, closing a stake of 6,384 shares — an estimated $67K sold.

LMR Partners first reported a position in BLCM in Q1 2017 and held it in 3 quarters. The position peaked at $3.34M in Q1 2017. 51 funds tracked by Wall St. Rank hold BLCM as of Q4 2019.

  • LMR Partners reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
  • LMR Partners sold 6,384 Bellicum Pharmaceuticals, Inc. shares in Q4 2019, an estimated $67K.
  • LMR Partners first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2017 and held it in 3 quarters.
  • LMR Partners's Bellicum Pharmaceuticals, Inc. position peaked at $3.34M in Q1 2017.
  • 51 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q4 2019.

Based on LMR Partners's 13F filing for Q4 2019, filed 14 Feb 2020.